Replies to post #79577 on Biotech Values

[DewDiligence]

I don't recall the press characterizing MNTA as a rival to TEVA before. Is this a new characterization?

I don’t recall seeing the word rival used previously, but the companies are indeed rivals with respect to generic Lovenox insofar as both have ANDA’s pending.

With respect to Copaxone, I would describe the companies as adversaries rather than rivals. Regards, Dew